- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01948258
Clearblue Advanced Fertility Monitor Consumer One Cycle at Home Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Clearblue Fertility Monitor is a personal monitor designed to be used with disposable test sticks for the semi-quantitative measurement of estrone-3-glucuronide (E3G) and luteinising hormone (LH) in women's urine. This personal information allows women to identify their fertile window and appropriately time intercourse in order to maximise their chances of conception. A new version of this monitor (Clearblue Advanced Fertility Monitor) has been developed with additional functionality including the option to test for pregnancy.
This study will assess the volunteer ease of use of the new Clearblue Advanced Fertility Monitor and the understanding and interpretation of the results by the user. This is a single centre clinical study which will be conducted by volunteers at their residence and co-ordinated by the clinical department at SPD Development Company Ltd.
A minimum of 100 female volunteers representing the target consumer will be required to use the new Clearblue Advanced Fertility Monitor at home as per the instructions for use. This will involve them setting up the monitor, using the monitor for one full cycle and then setting up the monitor for their next cycle unless they test for pregnancy and get a pregnant result.
At the end of one full cycle, all volunteers will complete a study questionnaire which includes sections on comprehension of the instructions for use, ease of use and interpretation of test results.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bedfordshire
-
Bedford, Bedfordshire, United Kingdom, MK43 7JX
- SPD Development Company Ltd
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female
- Aged 18 - 45 years
- Willing to provide written informed consent to participate in the study and comply to the investigational procedures
- Naive to similar marketed products including current Clearblue fertility monitor and Persona
- Two natural cycles immediately prior to entering the study, each lasting between 21 and 42 days
- Seeking to become pregnant
Exclusion Criteria:
- Unwilling to provide written informed consent to participate in the study or comply with study procedures
- Employees of SPD, Proctor & Gamble or Alere
- Have a condition that is known to be contra-indicated in pregnancy
- Usually have menstrual cycles which are shorter than 21 days or longer than 42 days
- Using or have used in their last 2 cycles, hormonal contraceptives including oral, emergency oral, implants, patches, transdermal injections, vaginal ring and progesterone intrauterine systems (IUS)
- Using or have used in the last 2 cycles, infertility medications or hormone replacement therapy containing hCG or LH
- Taking clomiphene citrate or other ovulation induction drugs
- Are using any treatment which may affect the menstrual cycle
- Have recently been pregnant, miscarried or breastfeeding
- Have been diagnosed with polycystic ovarian syndrome (PCOS)
- Are peri- or post-menopausal e.g. experiencing symptoms such as irregular menstrual periods, hot flushes, night sweats, sleep disturbances and mood swings
- Are taking antibiotics containing tetracyclines
- Have impaired liver or kidney function
- Have previously participated in a SPD 'trying to conceive' study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Clearblue Advanced Fertility Monitor
Use of Clearblue Fertility Monitor
|
Clearblue Advanced Fertility Monitor used for one menstrual cycle in a home setting
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Ability of the Volunteer to Use the New Clearblue Advanced Fertility Monitoring a Home Setting
Time Frame: one month use
|
Acceptance criteria is that ≥80% of volunteers will score 3 or less on the Likert scale in a home setting by demonstrating ease of use and comprehension of the instructions for use.
|
one month use
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correct Identification of Monitor Status
Time Frame: one month
|
To demonstrate correct user identification of fertility status and test days and to determine the performance of the monitor in consumer hands.
|
one month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pregnancy Test Result
Time Frame: one month
|
Pregnancy test results will also be compared with both the performance of a currently marketed pregnancy test when used by a trained technician and quantitative hCG concentration.
|
one month
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Sarah Johnson, PhD, SPD Swiss Precision Diagnostics GmbH
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 0481
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Hopital Antoine BeclereUnknown
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
-
Jagiellonian UniversityCompleted
Clinical Trials on Clearblue Advanced Fertility Monitor
-
Marquette UniversityCompleted
-
SPD Development Company LimitedCompleted
-
Quanovate Tech Inc.Completed
-
Northwestern UniversityAnn & Robert H Lurie Children's Hospital of ChicagoCompletedAllergy | Asthma in ChildrenUnited States
-
Yi YangNot yet recruitingAcute Ischemic StrokeChina
-
Duke UniversityRecruitingRotator Cuff Injuries | Shoulder Injuries | Shoulder Pain | Rotator Cuff Repair | Rotator Cuff Tears | Shoulder Surgery | Shoulder Arthritis | Shoulder Disease | Rotator Cuff Arthropathy of Left Shoulder | Rotator Cuff Arthropathy of Right ShoulderUnited States
-
W.J. PasmanCompletedHealth Behaviour Change | Self-monitoring of HealthNetherlands
-
University of California, San FranciscoCompleted
-
The Catholic University of KoreaWithdrawnthe Effect of Dexmedetomidine and Licodaine on Acute Postoperative Pain in Gynecological LaparoscopyGynecologic DiseaseKorea, Republic of